Skip to content

Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section

An Analysis of Risk Factors and Implementation of Strategies to Prevent Nausea and Vomiting in Patients Undergoing Regional Anesthesia for Caesarean Section

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04069806
Acronym
POC-NaVoP
Enrollment
140
Registered
2019-08-28
Start date
2019-09-03
Completion date
2021-08-31
Last updated
2020-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Keywords

Nausea, Vomiting, Oral carbohydrate, Fasting

Brief summary

Post-operative nausea and vomiting (PONV) in women undergoing subarachnoid anesthesia for Caesarean section is an important clinical problem. The aim of this study is to compare the effectiveness of oral carbohydrate loading to standard pre-operative fasting in patients undergoing elective cesarean section on the incidence and severity of PONV and biochemical parameters indicating ketosis.

Detailed description

Post-operative nausea and vomiting (PONV) in women undergoing subarachnoid anesthesia for Caesarean section is an important clinical problem. Known mechanisms underlying PONV are based on prolonged fasting, hypotension due to concomitant sympatholysis during anesthesia, bradycardia due to increased vagal tone, visceral stimulation during surgery and intrathecal administered opioids. However, the identification of patients exposed to this problem and appropriate perioperative preparation is of key importance. An analysis of risk factors for postoperative nausea and vomiting in patients undergoing elective cesarean section under spinal anesthesia is of major clinical importance. The aim of this study is a comparison of the effectiveness of oral carbohydrate loading strategy as compared with standard pre-operative fasting in patients undergoing elective cesarean section under spinal anesthesia on the incidence and severity of PONV and biochemical parameters indicating ketosis.

Interventions

DIETARY_SUPPLEMENTpreoperative oral carbohydrate, preOp

Patients in the experimental arm will receive oral carbohydrate preparation at 2 hours prior to planned caesarian section.

Sponsors

Pomeranian Medical University Szczecin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \>=18 years. 2. Scheduled for an elective cesarean section. 3. Uncomplicated pregnancy. 4. Planned for spinal anesthesia. 5. ASA I or ASA II.

Exclusion criteria

1. History of diabetes. 2. History of gastro-intestinal reflux (GERD). 3. Unable or unwilling to sign an informed consent. 4. Contraindications to spinal anesthesia. 5. Contraindication to Oral carbohydrate formula.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative nausea and vomiting 6 hours after caesarian section.6 hoursThe Postoperative Nausea and Vomiting (PONV) Intensity Scale 6 hours after caesarian section. Scale range: 0-50. The scale measures PONV intensity, where a score ≥50 defined clinically important PONV: PONV Intensity Scale=severity of nausea (1=mild, 2=moderate, 3=severe)×pattern of nausea (1=varying, 2=constant)×duration of nausea (in hours).
Postoperative nausea and vomiting 24 hours after caesarian section.24 hoursThe Postoperative Nausea and Vomiting (PONV) Intensity Scale 24 hours after caesarian section. Scale range: 0-50. The scale measures PONV intensity, where a score ≥50 defined clinically important PONV: PONV Intensity Scale=severity of nausea (1=mild, 2=moderate, 3=severe)×pattern of nausea (1=varying, 2=constant)×duration of nausea (in hours).

Secondary

MeasureTime frameDescription
Concentration of serum lactate in serum.0 hoursLactate level measured in maternal serum.
Concentration of beta-hydroxy-butiric acid in serum.0 hoursBeta-hydroxy-butiric acid level measured in maternal serum.
Time to first peristalsis.24 hoursMoment of first peristalsis after operation (in hours).
Concentration of isoprostane in urine.0 hoursIsoprostane level measured in maternal urine.
Insulin resistance factor (HOMA-IR).0 hoursInsulin resistance measured in maternal serum.
Time to first bowel movement.24 hoursMoment of first bowel movement after operation (in hours).

Countries

Poland

Contacts

Primary ContactKatarzyna L Kotfis, MD, PhD
katarzyna.kotfis@pum.edu.pl0048914661144
Backup ContactArleta Wojciechowska, RN
arletawoj@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026